A new study demonstrates how physicians can use genetic profiling of joint tissue to see which drugs will work for which patients.
Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.
Feinberg has been named as one of the top 20 best research-oriented medical schools in the country, according to the latest U.S. News & World Report rankings.
A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.
A new Northwestern Medicine study has discovered coffee changes many more metabolites in the blood than previously known, including those in the endocannabinoid system.
Northwestern Medicine scientists have identified a signaling protein that regulates cell organization, with implications for early development and certain diseases.
A Northwestern Medicine study provides new insights into the key role a molecule called oxPAPC plays in the inflammatory response. The findings could inform the development of new therapies for sepsis.
Northwestern Medicine scientists usher in a new era of genetic research. Learn how our investigators are using CRISPR technology to isolate mutations that cause neurological diseases and to understand how individual genes can damage or protect cells.
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.